Dyssomnias: Clinical Trials

203 trials for Dyssomnias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

203 completed. 203 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4203Completed 203

Follow Dyssomnias: new trials by email Literature Review of Dyssomnias trials Research Report on Dyssomnias

Trials (filtered) newest first · largest first

All 203 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EFFECT OF ZOLPIDEM ON SLEEP QUALITY AND OPIOID CONSUMPTION FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Zolpidem 10 mg tablets, Avocado-soybean unsaponifiables 300 mg - Postoperative Pain Management in Total Knee Arthroplasty
Phase 4CompletedSanatorio Allende542025-08-052026-09-03
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA
Dexmedetomidine-esketamine combination, Placebo - Obstructive Sleep Apnea, Surgery
Phase 4CompletedPeking University First Hospital1002024-09-112026-09-04
f Adding Ketamine to Propofol For Drug-induced Sleep Endoscopy in Adult Patients With Obstructive Sleep Apnea
Ketamine + propofol, propofol - Sleep Apnea Syndromes
Phase 4CompletedZagazig University302024-07-302026-09-10
HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men
Acetazolamide, Placebo - Sleep-Disordered Breathing
Phase 4CompletedUniversity of Zurich3032024-07-152026-06-05
Muscle Relaxation for Pediatric Adenotonsillectomy
Rocuronium, Sugammadex, Anesthesia without neuromuscular blockade - Tonsillectomy
Phase 4CompletedUniversity of Texas Southwestern Medical Center1722024-04-102025-07-28
Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality
Dexmedetomidine, Esketamine, Normal saline - Old Age, Knee Replacement Surgery
Phase 4CompletedPeking University First Hospital1542024-01-032026-07-06
Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality in ICU Patients
Dexmedetomidine-esketamine, Routine sedation and analgesia - Intensive Care Unit, Mechanical Ventilation
Phase 4CompletedPeking University First Hospital1742023-11-012025-12-05
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
Chloral Hydrate - Insomnia, Insomnia Chronic
Phase 4CompletedPharmanovia1002023-09-012024-11-07
Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA
Eszopiclone 3 mg, Placebo - Obstructive Sleep Apnea, Insomnia
Phase 4CompletedUniversity of Sao Paulo General Hospital602023-08-242026-05-29
Solriamfetol and CBT-I in Patients With Insomnia Disorder
Solriamfetol 75 MG, Cognitive Behavioral Therapy for Insomnia (CBT-I), Monitoring - Insomnia
Phase 4CompletedUniversity of Pennsylvania1152023-07-312026-05-12
A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
JZP258 (XYWAV) - Idiopathic Hypersomnia, Narcolepsy
Phase 4CompletedJazz Pharmaceuticals1992023-07-272026-08-27
A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
JZP258 - Narcolepsy
Phase 4CompletedJazz Pharmaceuticals1552023-06-262026-04-24
Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality
Dexmedetomidine, Esketamine, Normal saline - Breast Cancer, Perioperative Period
Phase 4CompletedPeking University First Hospital1802023-05-222025-07-31
Efficacy of Suvorexant on Post-operative Sleep Disturbance
Suvorexant, Placebo - Postoperative Insomnia, Postoperative Delirium
Phase 4CompletedColumbia University1002023-05-012026-07-23
Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Valerian-Hop Extract, Placebo - Sleep Disorders, Circadian Rhythm, Cognitive Dysfunction
Phase 4CompletedMax Zeller Soehne AG402023-03-012026-06-11
A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia
Daridorexant, Placebo - Insomnia Disorder, Nocturia
Phase 4CompletedIdorsia Pharmaceuticals Ltd.602023-02-162025-04-18
Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia
Suvorexant, Placebo - Insomnia, Metabolic Health
Phase 4CompletedBrigham and Women's Hospital312023-01-062026-04-16
Melatonin and DNA Damage Study
Melatonin, Placebo - Sleep Quality, DNA Damage Repair Deficiency
Phase 4CompletedUniversity of British Columbia402022-06-012024-08-28
Lemborexant Shift Work Treatment Study
Lemborexant, Placebo - Shift-Work Related Sleep Disturbance
Phase 4CompletedUniversity of California, San Francisco292022-03-102026-02-04
CBT-I or Zolpidem/Trazodone for Insomnia
Zolpidem, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), Trazodone - Chronic Insomnia
Phase 4CompletedCalifornia Pacific Medical Center Research Institute1552022-02-252025-02-24

Showing 20 of 203. Sign in to see all of them.

Narrower conditions

Sleep Initiation and Maintenance Disorders (81)  ·  Sleep Apnea, Obstructive (52)  ·  Sleep Apnea Syndromes (41)  ·  Restless Legs Syndrome (17)  ·  Sleep Wake Disorders (15)  ·  Disorders of Excessive Somnolence (12)  ·  Sleep Deprivation (10)  ·  Depression (9)  ·  Hypertension (9)  ·  Heart Failure (5)  ·  Hypoxia (5)  ·  Sleep Disorders, Circadian Rhythm (5)  ·  Anxiety Disorders (4)  ·  Apnea (4)  ·  Cardiovascular Diseases (4)

Broader conditions

Nervous System Diseases (203)  ·  Sleep Disorders, Intrinsic (190)  ·  Sleep Wake Disorders (188)  ·  Mental Disorders (130)  ·  Respiratory Tract Diseases (88)  ·  Respiration Disorders (84)  ·  Apnea (80)  ·  Pathological Conditions, Signs and Symptoms (61)  ·  Signs and Symptoms (54)  ·  Sleep Apnea Syndromes (43)  ·  Neurologic Manifestations (36)  ·  Cardiovascular Diseases (19)  ·  Parasomnias (17)  ·  Pathologic Processes (15)

Interventions

Zolpidem (22)  ·  Eszopiclone (16)  ·  Continuous Positive Airway Pressure (14)  ·  suvorexant (14)  ·  ramelteon (10)  ·  Dexmedetomidine (9)  ·  Modafinil (6)  ·  Pramipexole (6)  ·  Saline Solution (6)  ·  Acetazolamide (5)  ·  Propofol (5)  ·  Cognitive Behavioral Therapy (4)  ·  Sugammadex (4)  ·  1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid (3)  ·  Donepezil (3)

Sponsors

Peking University First Hospital (7)  ·  Astellas Pharma Inc (6)  ·  Hospital Universitario La Paz (6)  ·  Takeda (6)  ·  University of Zurich (6)  ·  Sanofi (5)  ·  Boehringer Ingelheim (4)  ·  China Medical University, China (4)  ·  Duke University (4)  ·  Jazz Pharmaceuticals (4)  ·  University of California, San Diego (4)  ·  University of Sao Paulo (4)  ·  Brigham and Women's Hospital (3)  ·  Centre Hospitalier Universitaire Vaudois (3)  ·  Cephalon (3)

Countries

United States (88)  ·  Spain (16)  ·  Canada (15)  ·  Brazil (12)  ·  Switzerland (12)  ·  China (11)  ·  Germany (10)  ·  France (9)  ·  Italy (8)  ·  Japan (8)  ·  United Kingdom (6)  ·  Belgium (5)  ·  Norway (5)  ·  Sweden (5)  ·  Taiwan (5)

Top investigators

Dong-Xin Wang, MD, PhD (4)  ·  Francisco Garcia-Rio, MD (4)  ·  Konrad E Bloch, MD (4)  ·  Phyllis Diener (3)  ·  Andrew D Krystal, MD (2)  ·  Andrew Krystal, MD (2)  ·  Christopher J Lettieri, MD (2)  ·  Daniel J. Buysse, MD (2)  ·  David L Steward, MD (2)

Results publications

PMID 21256799, PMID 34739082, PMID 38862381, PMID 10450601, PMID 10678860, PMID 10908222, PMID 10940788, PMID 11208620, PMID 11422885, PMID 14500166, PMID 16376782, PMID 16494088, PMID 16579514, PMID 16804151, PMID 17068990, PMID 17452537, PMID 17494787, PMID 17556718, PMID 17921053, PMID 17925431, PMID 17936040, PMID 17975198, PMID 1798888, PMID 18198262, PMID 18347202, PMID 18404673, PMID 18413499, PMID 18417099, PMID 18452788, PMID 18458174, PMID 18458207, PMID 18539753, PMID 18584016, PMID 18584227, PMID 18595959, PMID 18627623, PMID 18663661, PMID 18710420, PMID 18788656, PMID 18971479, PMID 19101028, PMID 19249441, PMID 19317379, PMID 19357147, PMID 19454639, PMID 19567493, PMID 19920270, PMID 20007932, PMID 20016520, PMID 20051221

NIH funding

2015 (2), K23MH066978 (1), P50AG016574 (1), R01AG015866 (1), R01AG028769 (1), R01AG053838 (1), R01AG054521 (1), R01HL130552 (1), R01MH024652 (1), R01MH060413 (1), R01MH095776 (1), R34MH070821 (1), R34MH091338 (1)